Croda International (CRDA)

Sector:

Industrial Chemicals

Index:

FTSE 100

4,902.00p
   
  • Change Today:
      49.00p
  • 52 Week High: 7,096.00
  • 52 Week Low: 4,076.00
  • Currency: UK Pounds
  • Shares Issued: 142.54m
  • Volume: 320,578
  • Market Cap: £6,987m
  • RiskGrade: 108

Croda buys vaccine adjuvant specialist for €70m

By Oliver Haill

Date: Monday 17 Dec 2018

LONDON (ShareCast) - (Sharecast News) - Chemicals group Croda International has wrapped up a deal to buy Denmark-based vaccine adjuvant specialist Brenntag Biosector for €72m.
Biosector, which is expected to be folded into the group by the end of the year, specialises in innovative aluminium and saponin-based adjuvants. Such adjuvants are widely used to increase their effectiveness of human and veterinary vaccines.

Croda said aluminium-based also provide a platform to introduce new technically advanced saponin-based adjuvants, with the addition of vaccine adjuvants being "a natural extension" to Croda's excipient delivery systems in its Health Care business.

"Biosector is a rare asset, in a high value, fast growing sector of the global pharmaceutical market," said Croda boss Steve Foots.

"With an experienced high-quality team, Biosector brings world-class protected technologies and industry-leading manufacturing facilities. Furthermore, the strong cultural alignment between Biosector and Croda enhances our highly technical-based sales approach and emphasis on value over volume."

He added that adjuvants represent a niche, high-growth market, driven by increased healthcare spending alongside advances in biotechnology and the growing need for preventative treatments.



Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

CRDA Market Data

Currency UK Pounds
Share Price 4,902.00p
Change Today 49.00p
% Change 1.01 %
52 Week High 7,096.00
52 Week Low 4,076.00
Volume 320,578
Shares Issued 142.54m
Market Cap £6,987m
RiskGrade 108

CRDA Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
83.73% below the market average83.73% below the market average83.73% below the market average83.73% below the market average83.73% below the market average
87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average87.5% below the sector average
Price Trend
24.23% below the market average24.23% below the market average24.23% below the market average24.23% below the market average24.23% below the market average
44.44% above the sector average44.44% above the sector average44.44% above the sector average44.44% above the sector average44.44% above the sector average
Income
84.36% below the market average84.36% below the market average84.36% below the market average84.36% below the market average84.36% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Growth
86.68% below the market average86.68% below the market average86.68% below the market average86.68% below the market average86.68% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

What The Brokers Say

Strong Buy 5
Buy 1
Neutral 9
Sell 0
Strong Sell 1
Total 16
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

CRDA Dividends

  Latest Previous
  Final Interim
Ex-Div 18-Apr-24 31-Aug-23
Paid 29-May-24 03-Oct-23
Amount 62.00p 47.00p

Trades for 28-Mar-2024

Time Volume / Share Price
16:35 236,539 @ 4,902.00p
16:35 217 @ 4,902.00p
16:35 288 @ 4,902.00p
16:35 360 @ 4,902.00p
16:35 1,016 @ 4,902.00p

CRDA Key Personnel

Chair Anita Frew
Finance Director Louisa Burdett

Top of Page